https://scholars.lib.ntu.edu.tw/handle/123456789/581824
標題: | Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma | 作者: | Hu M.-H. Huang T.-T. Chao T.-I. Chen L.-J. Chen Y.-L. Tsai M.-H. Liu C.-Y. JIA-HORNG KAO Chen K.-F. |
關鍵字: | AMP-activated protein kinase; cantharidin; cholangiocarcinoma; protein phosphatase 5 | 公開日期: | 2018 | 出版社: | Blackwell Publishing Ltd | 卷: | 38 | 期: | 12 | 起(迄)頁: | 2248-2259 | 來源出版物: | Liver International | 摘要: | Background & Aims: Few molecules are currently verified to be actionable drug targets in cholangiocarcinoma (CCA). Serine/threonine protein phosphatase 5 (PP5) dysregulation is related to several malignancies. However, the role of PP5 in CCA is poorly defined. Methods: Colony and tumorsphere formation assays were conducted to establish the role of PP5 in CCA tumorigenesis. Cantharidin (CTD) and norcantharidin (NCTD), both potent PP5 inhibitors, were used in in vitro and in vivo experiments to validate the potential therapeutic role of PP5. Results: Increased cell growth, colony formation and tumorsphere formation were observed in PP5-overexpressing CCA cells, whereas PP5 knockdown by shRNA decreased cell growth and colony formation. Tumours from HuCCT1 xenograft-bearing mice treated with PP5-shRNA showed decreased growth and increased AMP-activated protein kinase (AMPK) phosphorylation. Furthermore, CTD treatment decreased cell viability, reduced PP5 activity and enhanced AMPK phosphorylation in CCA cell lines. Overexpressing PP5 or enhancing PP5 activity suppressed AMPK phosphorylation and decreased CTD-induced cell death. Suppressing p-AMPK with siRNA or inhibitors also decreased CTD-induced cell death, suggesting a pivotal role for PP5-AMPK cascades in CCA. Immunoprecipitation revealed that PP5 interacted with AMPK. Importantly, treatment of HuCCT1 xenograft-bearing mice with NCTD, a CTD analogue with a lower systemic toxicity in vivo, suppressed PP5 activity, increased p-AMPK and reduced tumour volume. Conclusions: Protein phosphatase 5 negatively regulates AMPK phosphorylation and contributes to CCA aggressiveness; thus, PP5 may be a potential therapeutic target in CCA. ? 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057152124&doi=10.1111%2fliv.13887&partnerID=40&md5=82f6768c3dbaf9dfaf671cfdc71e0fd2 https://scholars.lib.ntu.edu.tw/handle/123456789/581824 |
ISSN: | 1478-3223 | DOI: | 10.1111/liv.13887 | SDG/關鍵字: | cantharidin; caspase 9; cyclin D1; hydroxymethylglutaryl coenzyme A reductase kinase; norcantharidin; phosphoprotein phosphatase; serine threonine protein phosphatase 5; short hairpin RNA; unclassified drug; antineoplastic agent; cantharidin; enzyme inhibitor; hydroxymethylglutaryl coenzyme A reductase kinase; nuclear protein; phosphoprotein phosphatase; protein phosphatase 5; animal cell; animal experiment; animal model; animal tissue; antineoplastic activity; apoptosis; Article; bile duct carcinoma; cancer inhibition; carcinogenesis; cell growth; cell survival; cell viability; colony formation; controlled study; drug targeting; gene knockdown; immunoprecipitation; in vitro study; in vivo study; male; mouse; nonhuman; protein dephosphorylation; protein phosphorylation; tumor volume; tumor xenograft; animal; antagonists and inhibitors; bile duct cancer; bile duct carcinoma; carcinogenesis; cell proliferation; drug screening; genetics; human; knockout mouse; metabolism; nude mouse; pathology; tumor cell line; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cantharidin; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Enzyme Inhibitors; Humans; Male; Mice; Mice, Knockout; Mice, Nude; Nuclear Proteins; Phosphoprotein Phosphatases; Xenograft Model Antitumor Assays |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。